Are you over 18 and want to see adult content?
More Annotations
A complete backup of seomarketing.com.br
Are you over 18 and want to see adult content?
A complete backup of listingstoleads.com
Are you over 18 and want to see adult content?
A complete backup of stockyardsrodeo.com
Are you over 18 and want to see adult content?
A complete backup of wissenschaft-im-dialog.de
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of europeluxurycars.com
Are you over 18 and want to see adult content?
A complete backup of gene-simmons.com
Are you over 18 and want to see adult content?
Text
pump for
ARTIFICIAL HEART TIMELINE 1973. Calf “Tony” lives 30 days on an early Kolff Total Artificial Heart (TAH). 1976. Calf “Abebe” lives for 184 days on the Jarvik 5 TAH. The Jarvik 5 TAH*. 1981. Calf “Alfred Lord Tennyson” lives for 268 days on the Jarvik 5 TAH. Don Olsen with “Alfred Lord Tennyson”*. Dr. Kolff submits a 50CC TOTAL ARTIFICIAL HEART The SynCardia 50cc temporary Total Artificial Heart (TAH) is a smaller version of the SynCardia 70cc TAH, which has been approved as a bridge to transplant for more than a decade. The 50cc TAH is designed for use as a bridge to transplant in patients of smaller stature, allowing more women and adolescents to access this novel technology. COMPANION 2 HOSPITAL DRIVER Companion 2 Hospital Driver. The state-of-the-art Companion 2 (C2) Hospital Driver provides pneumatic power to the SynCardia temporary Total Artificial Heart (TAH) from implant through patient recovery in the hospital. The C2 Driver monitors the TAH without the use of electrical connections to or inside the patient. SYMPTOMS AND PROGRESSION OF HEART FAILURE Symptoms of Heart Failure. According to the AHA, patients suffering from heart failure may experience the following symptoms: Shortness of breath (dyspnea): Blood “backs up” in the vessels that return blood from the lungs to the heart because the heart can’t keep WHAT IS CARDIOMYOPATHY AND HOW SERIOUS IS ITHYPERTROPHIC CARDIOMYOPATHY— CAUSES THE WALLS OF THE VENTRICLES (USUALLY THE LEFT VENTRICLE) TO THICKENRESTRICTIVE CARDIOMYOPATHY— CAUSES THE HEART VENTRICLES TO BECOME RIGIDSEE MORE ON SYNCARDIA.COM THE IMPORTANCE OF A TRANSITION STRATEGY FOR ECMO PATIENTS The new UNOS Adult Heart Allocation Policy heightens the importance of timely transition to a durable mechanical circulatory support device. Worldwide utilization of veno-arterial extracorporeal membrane oxygenation (VA ECMO) has risen sharply in recent years. 1 Between 2006 and 2011, the use of VA ECMO rose as much as 411% in the UnitedStates
HOME - SYNCARDIASYNCARDIACOOKIE POLICYOUR PRODUCTSIMAGE GALLERYABOUT SYNCARDIAWORLD'S ONLYRECENT NEWS This is an example page. It’s different from a blog post because it will stay in one place and will show up in your site navigation (in most themes). Most people start with an About page that introduces them to potential site visitors. It might say something like this: Hi there! I’m a bike messenger Continue reading CAREERS - SYNCARDIASYNCARDIA Careers. SynCardia Systems, LLC, headquartered in Tucson, Arizona, is a fast-paced, rapidly growing medical device company committed to saving the lives of patients with end-stage heart failure through innovative heart replacement technology. DOWNLOAD PRODUCT OVERVIEW SynCardia - Manufactures the SynCardia temporary Total Artificial Heart for patients with end-stage, biventricular heart failure in need of a donor heart transplant FREEDOM PORTABLE DRIVER The SynCardia temporary Total Artificial Heart (TAH) gives patients a second chance at life, and the Freedom® Portable Driver gives them the power to live it to the fullest. After a TAH patient becomes clinically stable, they can be switched from the Companion 2 (C2) Hospital Driver to the Freedom Driver, a smaller, lighter pneumaticpump for
ARTIFICIAL HEART TIMELINE 1973. Calf “Tony” lives 30 days on an early Kolff Total Artificial Heart (TAH). 1976. Calf “Abebe” lives for 184 days on the Jarvik 5 TAH. The Jarvik 5 TAH*. 1981. Calf “Alfred Lord Tennyson” lives for 268 days on the Jarvik 5 TAH. Don Olsen with “Alfred Lord Tennyson”*. Dr. Kolff submits a 50CC TOTAL ARTIFICIAL HEART The SynCardia 50cc temporary Total Artificial Heart (TAH) is a smaller version of the SynCardia 70cc TAH, which has been approved as a bridge to transplant for more than a decade. The 50cc TAH is designed for use as a bridge to transplant in patients of smaller stature, allowing more women and adolescents to access this novel technology. COMPANION 2 HOSPITAL DRIVER Companion 2 Hospital Driver. The state-of-the-art Companion 2 (C2) Hospital Driver provides pneumatic power to the SynCardia temporary Total Artificial Heart (TAH) from implant through patient recovery in the hospital. The C2 Driver monitors the TAH without the use of electrical connections to or inside the patient. SYMPTOMS AND PROGRESSION OF HEART FAILURE Symptoms of Heart Failure. According to the AHA, patients suffering from heart failure may experience the following symptoms: Shortness of breath (dyspnea): Blood “backs up” in the vessels that return blood from the lungs to the heart because the heart can’t keep WHAT IS CARDIOMYOPATHY AND HOW SERIOUS IS ITHYPERTROPHIC CARDIOMYOPATHY— CAUSES THE WALLS OF THE VENTRICLES (USUALLY THE LEFT VENTRICLE) TO THICKENRESTRICTIVE CARDIOMYOPATHY— CAUSES THE HEART VENTRICLES TO BECOME RIGIDSEE MORE ON SYNCARDIA.COM THE IMPORTANCE OF A TRANSITION STRATEGY FOR ECMO PATIENTS The new UNOS Adult Heart Allocation Policy heightens the importance of timely transition to a durable mechanical circulatory support device. Worldwide utilization of veno-arterial extracorporeal membrane oxygenation (VA ECMO) has risen sharply in recent years. 1 Between 2006 and 2011, the use of VA ECMO rose as much as 411% in the UnitedStates
OUR PRODUCTS
Our Products. SynCardia is the sole provider of the world’s only heart replacement technology with commercial approval in the U.S., Canada and Europe. By partnering with, training and supporting healthcare teams at more than 140 transplant hospitals and mechanical circulatory support (MCS) programs around the world, SynCardia helpscreate
PATIENT SELECTION
The SynCardia temporary Total Artificial Heart (TAH) is a clinically proven life-saving treatment option for cardiac transplant-eligible patients at risk of imminent death from biventricular failure. The TAH increases their chances of survival, allows them to enjoy a good quality of life at home and prepares them for transplant by increasingPATIENT MANAGEMENT
Some SynCardia Certified Centers tolerate Hgb as low as 6 g/dL and HCT as low as 17% as long as the patient is hemodynamically stable and asymptomatic 1,2. Maintain normal blood pressure – manage pharmacologically. Changing the driver settings will not change blood pressure. Antithrombotic management is geared towards the fourmechanical valves.
50CC TOTAL ARTIFICIAL HEART The SynCardia 50cc temporary Total Artificial Heart (TAH) is a smaller version of the SynCardia 70cc TAH, which has been approved as a bridge to transplant for more than a decade. The 50cc TAH is designed for use as a bridge to transplant in patients of smaller stature, allowing more women and adolescents to access this novel technology.RECENT NEWS
National Institute of Cardiovascular Diseases Implants First SynCardia Total Artificial Heart in Slovakia. The 47-year-old patient, who received the SynCardia TAH in November, is currently waiting for a matching donor heart at home with his family using the Freedom®Portable Driver.
DIRECTOR OF PROGRAM MANAGEMENT General Information Date Job Description Completed: April 20, 2021 Reports to: Vice President of Operations Supervises: Program Managers Exempt/Nonexempt: Exempt Essential Duties and Responsibilities Department Specific Duties and Responsibilities Provides strategic direction for the SynCardia TAH-t and Driver System development and engineering projects. Advises senior IMPLANTING THE SYNCARDIA TAH Adachi I, Morales DSL. Journal of Visualized Experiments. 2014;(89).doi:10.3791/51569.
COMPANION 2 HOSPITAL DRIVER Companion 2 Hospital Driver. The state-of-the-art Companion 2 (C2) Hospital Driver provides pneumatic power to the SynCardia temporary Total Artificial Heart (TAH) from implant through patient recovery in the hospital. The C2 Driver monitors the TAH without the use of electrical connections to or inside the patient.CLINICIAN GUIDES
Guide for Patients & Their Families. Download. Mktg-849 Rev 001. Download Patient Selection Guide. ×. Thank you for contacting us. We will get back to you shortly. ×. Please note that due to new privacy and data protection regulations, the information you are providing on this form cannot be submitted unless you give SynCardia consent to WHAT ARE THE DIFFERENCES BETWEEN AN LVAD AND THE TAH An LVAD is an implantable, mechanical pump that attaches directly to the patient’s heart. It is designed to assist, or in severe cases, take over, the pumping function of the left ventricle. The device is implanted in the abdomen, just below the diaphragm, and pumps blood from the left ventricle (the main pumping chamber of the heart) to the HOME - SYNCARDIASYNCARDIACOOKIE POLICYOUR PRODUCTSIMAGE GALLERYABOUT SYNCARDIAWORLD'S ONLYRECENT NEWS This is an example page. It’s different from a blog post because it will stay in one place and will show up in your site navigation (in most themes). Most people start with an About page that introduces them to potential site visitors. It might say something like this: Hi there! I’m a bike messenger Continue reading ARTIFICIAL HEART TIMELINE 1973. Calf “Tony” lives 30 days on an early Kolff Total Artificial Heart (TAH). 1976. Calf “Abebe” lives for 184 days on the Jarvik 5 TAH. The Jarvik 5 TAH*. 1981. Calf “Alfred Lord Tennyson” lives for 268 days on the Jarvik 5 TAH. Don Olsen with “Alfred Lord Tennyson”*. Dr. Kolff submits a DOWNLOAD PRODUCT OVERVIEW SynCardia - Manufactures the SynCardia temporary Total Artificial Heart for patients with end-stage, biventricular heart failure in need of a donor heart transplant CAREERS - SYNCARDIASYNCARDIA Careers. SynCardia Systems, LLC, headquartered in Tucson, Arizona, is a fast-paced, rapidly growing medical device company committed to saving the lives of patients with end-stage heart failure through innovative heart replacement technology. HOW DOES THE SYNCARDIA TOTAL ARTIFICIAL HEART WORK Just like a human heart, the SynCardia temporary Total Artificial Heart (TAH) is pulsatile and consists of two ventricles and four valves that pump blood throughout the body. The SynCardia TAH is made of a special biocompatible plastic, which offers a high degree of fatigue resistance and strength for long-term durability. Ventricles. FREEDOM PORTABLE DRIVER The SynCardia temporary Total Artificial Heart (TAH) gives patients a second chance at life, and the Freedom® Portable Driver gives them the power to live it to the fullest. After a TAH patient becomes clinically stable, they can be switched from the Companion 2 (C2) Hospital Driver to the Freedom Driver, a smaller, lighter pneumaticpump for
CLINICIAN GUIDES
Guide for Patients & Their Families. Download. Mktg-849 Rev 001. Download Patient Selection Guide. ×. Thank you for contacting us. We will get back to you shortly. ×. Please note that due to new privacy and data protection regulations, the information you are providing on this form cannot be submitted unless you give SynCardia consent to DIRECTOR OF PROGRAM MANAGEMENT General Information Date Job Description Completed: April 20, 2021 Reports to: Vice President of Operations Supervises: Program Managers Exempt/Nonexempt: Exempt Essential Duties and Responsibilities Department Specific Duties and Responsibilities Provides strategic direction for the SynCardia TAH-t and Driver System development and engineering projects. Advises seniorSUSTAINING ENGINEER
General Information Date Job Description Completed: April 2021 Reports to: Production Manager or Failure Investigation Manager and Sr. Mechanical Engineer Supervises: N/A Exempt/Nonexempt: Exempt Essential Duties and Responsibilities Department Specific Duties and Responsibilities Provide engineering and project support for existing Total Artificial Heart System products in sustaining SYMPTOMS AND PROGRESSION OF HEART FAILURE Symptoms of Heart Failure. According to the AHA, patients suffering from heart failure may experience the following symptoms: Shortness of breath (dyspnea): Blood “backs up” in the vessels that return blood from the lungs to the heart because the heart can’t keep HOME - SYNCARDIASYNCARDIACOOKIE POLICYOUR PRODUCTSIMAGE GALLERYABOUT SYNCARDIAWORLD'S ONLYRECENT NEWS This is an example page. It’s different from a blog post because it will stay in one place and will show up in your site navigation (in most themes). Most people start with an About page that introduces them to potential site visitors. It might say something like this: Hi there! I’m a bike messenger Continue reading ARTIFICIAL HEART TIMELINE 1973. Calf “Tony” lives 30 days on an early Kolff Total Artificial Heart (TAH). 1976. Calf “Abebe” lives for 184 days on the Jarvik 5 TAH. The Jarvik 5 TAH*. 1981. Calf “Alfred Lord Tennyson” lives for 268 days on the Jarvik 5 TAH. Don Olsen with “Alfred Lord Tennyson”*. Dr. Kolff submits a DOWNLOAD PRODUCT OVERVIEW SynCardia - Manufactures the SynCardia temporary Total Artificial Heart for patients with end-stage, biventricular heart failure in need of a donor heart transplant CAREERS - SYNCARDIASYNCARDIA Careers. SynCardia Systems, LLC, headquartered in Tucson, Arizona, is a fast-paced, rapidly growing medical device company committed to saving the lives of patients with end-stage heart failure through innovative heart replacement technology. HOW DOES THE SYNCARDIA TOTAL ARTIFICIAL HEART WORK Just like a human heart, the SynCardia temporary Total Artificial Heart (TAH) is pulsatile and consists of two ventricles and four valves that pump blood throughout the body. The SynCardia TAH is made of a special biocompatible plastic, which offers a high degree of fatigue resistance and strength for long-term durability. Ventricles. FREEDOM PORTABLE DRIVER The SynCardia temporary Total Artificial Heart (TAH) gives patients a second chance at life, and the Freedom® Portable Driver gives them the power to live it to the fullest. After a TAH patient becomes clinically stable, they can be switched from the Companion 2 (C2) Hospital Driver to the Freedom Driver, a smaller, lighter pneumaticpump for
CLINICIAN GUIDES
Guide for Patients & Their Families. Download. Mktg-849 Rev 001. Download Patient Selection Guide. ×. Thank you for contacting us. We will get back to you shortly. ×. Please note that due to new privacy and data protection regulations, the information you are providing on this form cannot be submitted unless you give SynCardia consent to DIRECTOR OF PROGRAM MANAGEMENT General Information Date Job Description Completed: April 20, 2021 Reports to: Vice President of Operations Supervises: Program Managers Exempt/Nonexempt: Exempt Essential Duties and Responsibilities Department Specific Duties and Responsibilities Provides strategic direction for the SynCardia TAH-t and Driver System development and engineering projects. Advises seniorSUSTAINING ENGINEER
General Information Date Job Description Completed: April 2021 Reports to: Production Manager or Failure Investigation Manager and Sr. Mechanical Engineer Supervises: N/A Exempt/Nonexempt: Exempt Essential Duties and Responsibilities Department Specific Duties and Responsibilities Provide engineering and project support for existing Total Artificial Heart System products in sustaining SYMPTOMS AND PROGRESSION OF HEART FAILURE Symptoms of Heart Failure. According to the AHA, patients suffering from heart failure may experience the following symptoms: Shortness of breath (dyspnea): Blood “backs up” in the vessels that return blood from the lungs to the heart because the heart can’t keepOUR PRODUCTS
Our Products. SynCardia is the sole provider of the world’s only heart replacement technology with commercial approval in the U.S., Canada and Europe. By partnering with, training and supporting healthcare teams at more than 140 transplant hospitals and mechanical circulatory support (MCS) programs around the world, SynCardia helpscreate
SYNCARDIA TEMPORARY TOTAL ARTIFICIAL HEART The SynCardia Total Artificial Heart (TAH) is a clinically proven life-saving treatment option for cardiac transplant-eligible patients at risk of imminent death from biventricular failure.ABOUT SYNCARDIA
Headquartered in Tucson, Arizona, SynCardia was founded in 2001 by renowned cardiothoracic surgeon Jack G. Copeland, MD; biomedical engineer Richard G. Smith, MSEE, CCE; and interventional cardiologist Marvin J. Slepian, MD. Today, SynCardia is the sole manufacturer and provider of the world’s only commercially approved total artificialheart.
PATIENT MANAGEMENT
Some SynCardia Certified Centers tolerate Hgb as low as 6 g/dL and HCT as low as 17% as long as the patient is hemodynamically stable and asymptomatic 1,2. Maintain normal blood pressure – manage pharmacologically. Changing the driver settings will not change blood pressure. Antithrombotic management is geared towards the fourmechanical valves.
CLINICIAN GUIDES
Guide for Patients & Their Families. Download. Mktg-849 Rev 001. Download Patient Selection Guide. ×. Thank you for contacting us. We will get back to you shortly. ×. Please note that due to new privacy and data protection regulations, the information you are providing on this form cannot be submitted unless you give SynCardia consent to 50CC TOTAL ARTIFICIAL HEART The SynCardia 50cc temporary Total Artificial Heart (TAH) is a smaller version of the SynCardia 70cc TAH, which has been approved as a bridge to transplant for more than a decade. The 50cc TAH is designed for use as a bridge to transplant in patients of smaller stature, allowing more women and adolescents to access this novel technology. IMPLANTING THE SYNCARDIA TAH Adachi I, Morales DSL. Journal of Visualized Experiments. 2014;(89).doi:10.3791/51569.
COMPANION 2 HOSPITAL DRIVER Companion 2 Hospital Driver. The state-of-the-art Companion 2 (C2) Hospital Driver provides pneumatic power to the SynCardia temporary Total Artificial Heart (TAH) from implant through patient recovery in the hospital. The C2 Driver monitors the TAH without the use of electrical connections to or inside the patient. WHAT ARE THE DIFFERENCES BETWEEN AN LVAD AND THE TAH An LVAD is an implantable, mechanical pump that attaches directly to the patient’s heart. It is designed to assist, or in severe cases, take over, the pumping function of the left ventricle. The device is implanted in the abdomen, just below the diaphragm, and pumps blood from the left ventricle (the main pumping chamber of the heart) to the SPUS: THE SECRET BEHIND THE SUCCESS OF THE SYNCARDIA TAH Segmented polyurethane solution, or SPUS, is a highly durable and versatile chemical compound used to manufacture the SynCardia Total Artificial Heart (TAH). Because of its high degree of fatigue resistance, strength and biocompatibility, SPUS is ideally suited for use in the flexible and blood-contacting components of the TAH, whichincludes
HOME - SYNCARDIASYNCARDIACOOKIE POLICYOUR PRODUCTSIMAGE GALLERYABOUT SYNCARDIAWORLD'S ONLYRECENT NEWS This is an example page. It’s different from a blog post because it will stay in one place and will show up in your site navigation (in most themes). Most people start with an About page that introduces them to potential site visitors. It might say something like this: Hi there! I’m a bike messenger Continue reading DOWNLOAD PRODUCT OVERVIEW SynCardia - Manufactures the SynCardia temporary Total Artificial Heart for patients with end-stage, biventricular heart failure in need of a donor heart transplant CAREERS - SYNCARDIASYNCARDIA Careers. SynCardia Systems, LLC, headquartered in Tucson, Arizona, is a fast-paced, rapidly growing medical device company committed to saving the lives of patients with end-stage heart failure through innovative heart replacement technology.PATIENT SELECTION
The SynCardia temporary Total Artificial Heart (TAH) is a clinically proven life-saving treatment option for cardiac transplant-eligible patients at risk of imminent death from biventricular failure. The TAH increases their chances of survival, allows them to enjoy a good quality of life at home and prepares them for transplant by increasing FREEDOM PORTABLE DRIVER The SynCardia temporary Total Artificial Heart (TAH) gives patients a second chance at life, and the Freedom® Portable Driver gives them the power to live it to the fullest. After a TAH patient becomes clinically stable, they can be switched from the Companion 2 (C2) Hospital Driver to the Freedom Driver, a smaller, lighter pneumaticpump for
IMPLANTING THE SYNCARDIA TAH Adachi I, Morales DSL. Journal of Visualized Experiments. 2014;(89).doi:10.3791/51569.
50CC TOTAL ARTIFICIAL HEART The SynCardia 50cc temporary Total Artificial Heart (TAH) is a smaller version of the SynCardia 70cc TAH, which has been approved as a bridge to transplant for more than a decade. The 50cc TAH is designed for use as a bridge to transplant in patients of smaller stature, allowing more women and adolescents to access this novel technology. ARTIFICIAL HEART TIMELINE 1973. Calf “Tony” lives 30 days on an early Kolff Total Artificial Heart (TAH). 1976. Calf “Abebe” lives for 184 days on the Jarvik 5 TAH. The Jarvik 5 TAH*. 1981. Calf “Alfred Lord Tennyson” lives for 268 days on the Jarvik 5 TAH. Don Olsen with “Alfred Lord Tennyson”*. Dr. Kolff submits a SYMPTOMS AND PROGRESSION OF HEART FAILURE Symptoms of Heart Failure. According to the AHA, patients suffering from heart failure may experience the following symptoms: Shortness of breath (dyspnea): Blood “backs up” in the vessels that return blood from the lungs to the heart because the heart can’t keep SPUS: THE SECRET BEHIND THE SUCCESS OF THE SYNCARDIA TAHSEE MORE ONSYNCARDIA.COM
HOME - SYNCARDIASYNCARDIACOOKIE POLICYOUR PRODUCTSIMAGE GALLERYABOUT SYNCARDIAWORLD'S ONLYRECENT NEWS This is an example page. It’s different from a blog post because it will stay in one place and will show up in your site navigation (in most themes). Most people start with an About page that introduces them to potential site visitors. It might say something like this: Hi there! I’m a bike messenger Continue reading DOWNLOAD PRODUCT OVERVIEW SynCardia - Manufactures the SynCardia temporary Total Artificial Heart for patients with end-stage, biventricular heart failure in need of a donor heart transplant CAREERS - SYNCARDIASYNCARDIA Careers. SynCardia Systems, LLC, headquartered in Tucson, Arizona, is a fast-paced, rapidly growing medical device company committed to saving the lives of patients with end-stage heart failure through innovative heart replacement technology.PATIENT SELECTION
The SynCardia temporary Total Artificial Heart (TAH) is a clinically proven life-saving treatment option for cardiac transplant-eligible patients at risk of imminent death from biventricular failure. The TAH increases their chances of survival, allows them to enjoy a good quality of life at home and prepares them for transplant by increasing FREEDOM PORTABLE DRIVER The SynCardia temporary Total Artificial Heart (TAH) gives patients a second chance at life, and the Freedom® Portable Driver gives them the power to live it to the fullest. After a TAH patient becomes clinically stable, they can be switched from the Companion 2 (C2) Hospital Driver to the Freedom Driver, a smaller, lighter pneumaticpump for
IMPLANTING THE SYNCARDIA TAH Adachi I, Morales DSL. Journal of Visualized Experiments. 2014;(89).doi:10.3791/51569.
50CC TOTAL ARTIFICIAL HEART The SynCardia 50cc temporary Total Artificial Heart (TAH) is a smaller version of the SynCardia 70cc TAH, which has been approved as a bridge to transplant for more than a decade. The 50cc TAH is designed for use as a bridge to transplant in patients of smaller stature, allowing more women and adolescents to access this novel technology. ARTIFICIAL HEART TIMELINE 1973. Calf “Tony” lives 30 days on an early Kolff Total Artificial Heart (TAH). 1976. Calf “Abebe” lives for 184 days on the Jarvik 5 TAH. The Jarvik 5 TAH*. 1981. Calf “Alfred Lord Tennyson” lives for 268 days on the Jarvik 5 TAH. Don Olsen with “Alfred Lord Tennyson”*. Dr. Kolff submits a SYMPTOMS AND PROGRESSION OF HEART FAILURE Symptoms of Heart Failure. According to the AHA, patients suffering from heart failure may experience the following symptoms: Shortness of breath (dyspnea): Blood “backs up” in the vessels that return blood from the lungs to the heart because the heart can’t keep SPUS: THE SECRET BEHIND THE SUCCESS OF THE SYNCARDIA TAHSEE MORE ONSYNCARDIA.COM
OUR PRODUCTS
Our Products. SynCardia is the sole provider of the world’s only heart replacement technology with commercial approval in the U.S., Canada and Europe. By partnering with, training and supporting healthcare teams at more than 140 transplant hospitals and mechanical circulatory support (MCS) programs around the world, SynCardia helpscreate
ABOUT SYNCARDIA
Headquartered in Tucson, Arizona, SynCardia was founded in 2001 by renowned cardiothoracic surgeon Jack G. Copeland, MD; biomedical engineer Richard G. Smith, MSEE, CCE; and interventional cardiologist Marvin J. Slepian, MD. Today, SynCardia is the sole manufacturer and provider of the world’s only commercially approved total artificialheart.
EVENTS - SYNCARDIASYNCARDIA Webinar: Introduction to Syncardia’s Total Artificial Heart Join us for a live webinar on Tuesday, April 13th, 2021 from 7:00-8:00 pm EDT. Featuring speakers Dr. Jack Copeland and Dr. Francisco Arabia, this program intends to bridge existing knowledge gaps related to the history and importance of the SynCardia Total Artificial Heart. The webinar will be comprised of an informative lecturePATIENT SELECTION
The sooner you contact us about potential patients, the better prepared we can be to assist you. In addition, if you have a new team member or your personnel need a refresher on TAH implantation and patient management best practices, our Clinical Support Team is ready to provide the necessary training to ensure that your team is confident and prepared to meet every patient’s needs.PATIENT MANAGEMENT
Some SynCardia Certified Centers tolerate Hgb as low as 6 g/dL and HCT as low as 17% as long as the patient is hemodynamically stable and asymptomatic 1,2. Maintain normal blood pressure – manage pharmacologically. Changing the driver settings will not change blood pressure. Antithrombotic management is geared towards the fourmechanical valves.
IMPLANTING THE SYNCARDIA TAH Adachi I, Morales DSL. Journal of Visualized Experiments. 2014;(89).doi:10.3791/51569.
COMPANION 2 HOSPITAL DRIVER Companion 2 Hospital Driver. The state-of-the-art Companion 2 (C2) Hospital Driver provides pneumatic power to the SynCardia temporary Total Artificial Heart (TAH) from implant through patient recovery in the hospital. The C2 Driver monitors the TAH without the use of electrical connections to or inside the patient.TOM'S STORY
Tom was diagnosed with dilated cardiomyopathy caused by a rare disease called cardiac sarcoidosis. One day, Tom received 11 shocks in five minutes from his defibrillator. He was experiencing what is known as a “v-tach storm.” He woke up two days later in the ICU, where doctors told him he wouldn’t survive more than another day unless they took action. Read Tom's story. DIRECTOR OF PROGRAM MANAGEMENT General Information Date Job Description Completed: April 20, 2021 Reports to: Vice President of Operations Supervises: Program Managers Exempt/Nonexempt: Exempt Essential Duties and Responsibilities Department Specific Duties and Responsibilities Provides strategic direction for the SynCardia TAH-t and Driver System development and engineering projects. Advises seniorSTAN'S STORY
Stan was born with a life-threatening hereditary heart condition called arrhythmogenic right ventricular dysplasia (ARVD). Surgeons implanted a defibrillator to help regulate Stan’s heart rhythm, but over time, his condition deteriorated and his body began retaining fluid at an alarming rate. Read Stan's story. This site uses cookies as described in our Cookie Policyand Privacy Policy
to ensure you get the best experience on our website.Accept __
PATIENTS & FAMILIES
IF YOU OR A LOVED ONE HAS END-STAGE BIVENTRICULAR HEART FAILURE, THERE’S HOPE. WHEN A DONOR HEART ISN'T AN AVAILABLE OPTION, THE SYNCARDIA TEMPORARY TOTAL ARTIFICIAL HEART CAN PROVIDE THE NEW HEART YOU NEED WITHOUT THE WAIT.Enter Here
CLINICIANS
HELP YOUR PATIENTS LIVE LONGER, LIVE BETTER. THE SYNCARDIA TEMPORARY TOTAL ARTIFICIAL HEART IS A PROVEN, LIFE-SAVING TREATMENT OPTION FOR PATIENTS WITH END-STAGE BIVENTRICULAR FAILURE.Enter Here
FIND US ON SOCIAL MEDIA* __
* __
* __
2021 Copyright SynCardia Systems, LLC | About Us| Privacy Policy
| Careers
| Cookie Policy
CAUTION – In the United States, the use of the SynCardia 70cc TAH for destination therapy is investigational. DOWNLOAD ASSET FORMS×
We are collecting this information in order to evaluate the use and reach of our resources so that we can better serve our customers andtheir needs.
Close
INFORMATION
×
We are collecting this information in order to effectively respond to your inquiry, question(s) or comment(s). We also use this information to track the number and nature of form submissions we receive on ourwebsite.
Close
SYNCARDIA EMAIL SIGN-UP×
We are collecting this information so that we can send you emails about our latest news, resources, patient stories, announcements, blog posts and events, tailored to your location, job title and company.Close
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0